Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Iterum Therapeutics plc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 24 | +7 |
| Shares | 2.04M | 40 | 1.23M | −808.7K (−39.6%) |
| Value | $2.22M | $44 | $2.18M | −$48.5K (−2.2%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Iterum Therapeutics plc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 438,816 | $776.7K | 0.00% |
| Creative Financial Designs Inc | 59,900 | $106.0K | 0.01% |
| Two Sigma Investments, LP | 25,245 | $44.7K | 0.00% |
| Citadel Advisors LLC | 21,207 | $37.5K | 0.00% |
| Sanctuary Advisors, LLC | 20,000 | $31.4K | 0.00% |
| Lee Financial Co | 16,000 | $28.3K | 0.00% |
| Jane Street Group, LLC | 10,262 | $18.2K | 0.00% |
| Medallion Wealth Advisors, LLC | 1,680 | $2.07K | 0.00% |
| Tower Research Capital LLC (TRC) | 710 | $1.26K | 0.00% |
| Barclays PLC | 500 | $885 | 0.00% |
| Newbridge Financial Services Group, Inc. | 15 | $27 | 0.00% |
| SBI Securities Co., Ltd. | 14 | $25 | 0.00% |
Sold out (5)
Institutions that held Iterum Therapeutics plc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Armistice Capital, LLC | 1,340,000 | $1.46M |
| XTX Topco Ltd | 33,040 | $36.0K |
| Two Sigma Securities, LLC | 14,947 | $16.3K |
| National Bank of Canada | 2 | $2 |
| JPMorgan Chase & Co | 1 | $1 |
Not filed for Q4 2024 yet (1)
Institutions that held Iterum Therapeutics plc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Planning Capital Management Corp | 40 | $44 |